Montrusco Bolton Investments Inc. decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 10.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 98,925 shares of the company’s stock after selling 12,081 shares during the quarter. Montrusco Bolton Investments Inc. owned about 0.06% of Henry Schein worth $6,913,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Cambridge Investment Research Advisors Inc. raised its position in shares of Henry Schein by 4.1% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 2,182 shares of the company’s stock valued at $399,000 after buying an additional 86 shares in the last quarter. Chicago Equity Partners LLC purchased a new stake in Henry Schein in the 2nd quarter valued at about $281,000. State of Tennessee Treasury Department increased its stake in Henry Schein by 0.3% in the 2nd quarter. State of Tennessee Treasury Department now owns 21,697 shares of the company’s stock valued at $3,971,000 after buying an additional 66 shares during the last quarter. Commonwealth Bank of Australia increased its stake in Henry Schein by 14.7% in the 2nd quarter. Commonwealth Bank of Australia now owns 5,873 shares of the company’s stock valued at $1,073,000 after buying an additional 751 shares during the last quarter. Finally, Wells Fargo & Company MN increased its stake in Henry Schein by 6.1% in the 2nd quarter. Wells Fargo & Company MN now owns 136,032 shares of the company’s stock valued at $24,897,000 after buying an additional 7,775 shares during the last quarter. Hedge funds and other institutional investors own 91.69% of the company’s stock.
HSIC has been the subject of several analyst reports. Morgan Stanley lowered shares of Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 price objective for the company. in a research note on Wednesday, December 6th. Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a report on Friday, September 15th. Craig Hallum raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Tuesday, November 7th. Credit Suisse Group reissued a “neutral” rating and issued a $80.00 price target (down from $87.50) on shares of Henry Schein in a report on Tuesday, November 28th. Finally, Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Monday, November 13th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $84.23.
Henry Schein, Inc. (NASDAQ HSIC) traded up $0.51 during trading on Friday, hitting $73.30. 1,251,800 shares of the stock traded hands, compared to its average volume of 1,327,387. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. The stock has a market cap of $11,750.00, a PE ratio of 21.12, a P/E/G ratio of 1.89 and a beta of 0.99. Henry Schein, Inc. has a 12-month low of $65.28 and a 12-month high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.03). The company had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The business’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.84 EPS. equities research analysts forecast that Henry Schein, Inc. will post 3.6 EPS for the current year.
Henry Schein announced that its Board of Directors has authorized a share repurchase plan on Monday, September 18th that authorizes the company to buyback $400.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.3% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s management believes its stock is undervalued.
In other news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $70.76, for a total transaction of $410,124.96. Following the sale, the director now owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.19% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Henry Schein, Inc. (HSIC) Position Trimmed by Montrusco Bolton Investments Inc.” was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://ledgergazette.com/2018/01/12/henry-schein-inc-hsic-position-trimmed-by-montrusco-bolton-investments-inc.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.